Boundless Bio to Participate at Two Upcoming Investor Conferences

by Business Wire • 2022/11/15 • 0 Comments

SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its Chief Executive Officer, Zachary Hornby, will participate in a presentation and fireside chat at upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference Format: Presentation Date: Tuesday, November 29, 2022 Time: 8:30 AM – 8:50 AM ET 5th Annual Everco

← Worldwide Ophthalmic Sutures Industry to 2027 – Adoption of Minimally Invasive Surgeries and Absorbable Sutures is Driving Growth – ResearchAndMarkets.com

Global Optical Coherence Tomography for Ophthalmology Market to 2027 – Featuring Abbott Laboratories, Agfa-Gevaert, Canon Medical Systems and Carl Zeiss Among Others – ResearchAndMarkets.com →

Post navigation